Annual Revenue:
$332.31M+$215.98M(+185.66%)Summary
- As of today, ESPR annual revenue is $332.31 million, with the most recent change of +$215.98 million (+185.66%) on December 31, 2024.
- During the last 3 years, ESPR annual revenue has risen by +$253.87 million (+323.62%).
- ESPR annual revenue is now at all-time high.
Performance
ESPR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$87.31M+$4.92M(+5.98%)Summary
- As of today, ESPR quarterly revenue is $87.31 million, with the most recent change of +$4.92 million (+5.98%) on September 30, 2025.
- Over the past year, ESPR quarterly revenue has increased by +$35.68 million (+69.10%).
- ESPR quarterly revenue is now -58.86% below its all-time high of $212.24 million, reached on June 30, 2020.
Performance
ESPR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$303.80M+$35.68M(+13.31%)Summary
- As of today, ESPR TTM revenue is $303.80 million, with the most recent change of +$35.68 million (+13.31%) on September 30, 2025.
- Over the past year, ESPR TTM revenue has increased by +$8.35 million (+2.83%).
- ESPR TTM revenue is now -8.58% below its all-time high of $332.31 million, reached on December 31, 2024.
Performance
ESPR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ESPR Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +185.7% | +69.1% | +2.8% |
| 3Y3 Years | +323.6% | +360.0% | +321.6% |
| 5Y5 Years | +124.0% | +2177.8% | +38.8% |
ESPR Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +340.3% | -36.6% | +364.0% | -8.6% | +321.6% |
| 5Y | 5-Year | at high | +340.3% | -36.6% | +2177.8% | -8.6% | +389.1% |
| All-Time | All-Time | at high | >+9999.0% | -58.9% | >+9999.0% | -8.6% | >+9999.0% |
ESPR Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $87.31M(+6.0%) | $303.80M(+13.3%) |
| Jun 2025 | - | $82.39M(+26.8%) | $268.13M(+3.3%) |
| Mar 2025 | - | $65.00M(-6.0%) | $259.57M(-21.9%) |
| Dec 2024 | $332.31M(+185.7%) | $69.11M(+33.9%) | $332.31M(+12.5%) |
| Sep 2024 | - | $51.63M(-30.1%) | $295.45M(+6.4%) |
| Jun 2024 | - | $73.83M(-46.4%) | $277.79M(+20.9%) |
| Mar 2024 | - | $137.74M(+327.1%) | $229.74M(+97.5%) |
| Dec 2023 | $116.33M(+54.1%) | $32.25M(-5.1%) | $116.33M(+13.1%) |
| Sep 2023 | - | $33.97M(+31.7%) | $102.90M(+17.0%) |
| Jun 2023 | - | $25.79M(+6.0%) | $87.91M(+8.6%) |
| Mar 2023 | - | $24.33M(+29.3%) | $80.97M(+7.3%) |
| Dec 2022 | $75.47M(-3.8%) | $18.82M(-0.9%) | $75.47M(+4.7%) |
| Sep 2022 | - | $18.98M(+0.7%) | $72.06M(+6.8%) |
| Jun 2022 | - | $18.84M(+0.0%) | $67.49M(-24.4%) |
| Mar 2022 | - | $18.84M(+22.3%) | $89.31M(+13.8%) |
| Dec 2021 | $78.45M(-65.5%) | $15.40M(+6.9%) | $78.45M(+7.9%) |
| Sep 2021 | - | $14.41M(-64.6%) | $72.68M(+17.0%) |
| Jun 2021 | - | $40.66M(+409.6%) | $62.11M(-73.4%) |
| Mar 2021 | - | $7.98M(-17.2%) | $233.69M(+2.7%) |
| Dec 2020 | $227.55M(+53.4%) | $9.64M(+151.4%) | $227.55M(+4.0%) |
| Sep 2020 | - | $3.83M(-98.2%) | $218.89M(+1.3%) |
| Jun 2020 | - | $212.24M(>+9900.0%) | $216.04M(+4414.9%) |
| Mar 2020 | - | $1.84M(+87.4%) | $4.79M(-96.8%) |
| Dec 2019 | $148.36M(>+9900.0%) | $982.00K(+0.1%) | $148.36M(+0.7%) |
| Sep 2019 | - | $981.00K(-0.1%) | $147.38M(+0.7%) |
| Jun 2019 | - | $982.00K(-99.3%) | $146.40M(+0.7%) |
| Mar 2019 | - | $145.42M(>+9900.0%) | $145.42M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | - | - |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00(-100.0%) | - | - |
| Dec 2000 | $2000.00(+100.0%) | - | - |
| Dec 1999 | $1000.00 | - | - |
FAQ
- What is Esperion Therapeutics, Inc. annual revenue?
- What is the all-time high annual revenue for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. annual revenue year-on-year change?
- What is Esperion Therapeutics, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Esperion Therapeutics, Inc. TTM revenue?
- What is the all-time high TTM revenue for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. TTM revenue year-on-year change?
What is Esperion Therapeutics, Inc. annual revenue?
The current annual revenue of ESPR is $332.31M
What is the all-time high annual revenue for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high annual revenue is $332.31M
What is Esperion Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, ESPR annual revenue has changed by +$215.98M (+185.66%)
What is Esperion Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of ESPR is $87.31M
What is the all-time high quarterly revenue for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high quarterly revenue is $212.24M
What is Esperion Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, ESPR quarterly revenue has changed by +$35.68M (+69.10%)
What is Esperion Therapeutics, Inc. TTM revenue?
The current TTM revenue of ESPR is $303.80M
What is the all-time high TTM revenue for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high TTM revenue is $332.31M
What is Esperion Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, ESPR TTM revenue has changed by +$8.35M (+2.83%)